Revenue has plateaued near $320M to $375M per quarter with year-over-year growth of 17.4% in Q3 2026 against a much weaker 0.7% in Q3 2025, while net income of $163.4M and a 44.6% combined ratio suggest profitability remains strong but earnings quality warrants scrutiny given the low loss expense in 2024 and 2025.
Essent Group Ltd. (ESNT) annual income statement — 15-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Revenue | 1.38B | 1.26B | 1.27B | 1.13B | 1.02B | 1.03B | 955.15M | 867.57M | 719.35M | 576.51M | 458.26M | 353.29M | 239.47M | 131.4M | 48.72M | 14.39M |
| Revenue Growth % | 5.41% | -0.49% | 12.03% | 11.07% | -0.99% | 7.68% | 10.1% | 20.6% | 24.78% | 25.8% | 29.71% | 47.53% | 82.24% | 169.73% | 238.59% | - |
| Medical Costs & Claims | 236.74M | 149.34M | 81.22M | 31.54M | -174.7M | 31.06M | 301.29M | 32.99M | 11.57M | 27.23M | 0 | 0 | 6.31M | 2.32M | 0 | 0 |
| Medical Cost Ratio % | 17.17% | 11.84% | 6.41% | 2.79% | -17.16% | 3.02% | 31.54% | 3.8% | 1.61% | 4.72% | 0% | 0% | 2.63% | 1.77% | 0% | 0% |
| Gross Profit | 1.14B | 1.11B | 1.19B | 1.1B | 1.19B | 997.45M | 653.86M | 834.58M | 707.78M | 549.28M | 458.26M | 353.29M | 233.16M | 129.08M | 48.72M | 14.39M |
| Gross Margin % | 82.83% | 88.16% | 93.59% | 97.21% | 117.16% | 96.98% | 68.46% | 96.2% | 98.39% | 95.28% | 100% | 100% | 97.37% | 98.23% | 100% | 100% |
| Gross Profit Growth % | - | -6.27% | 7.86% | -7.84% | 19.61% | 52.55% | -21.65% | 17.92% | 28.86% | 19.86% | 29.71% | 51.52% | 80.63% | 164.97% | 238.59% | - |
| Operating Expenses | 313.38M | 289.74M | 330.44M | 276.54M | 204.85M | 175.14M | 163.76M | 175.52M | 161.08M | 150.71M | 146.38M | 124.89M | 97.23M | 71.06M | 62.59M | 48.84M |
| OpEx / Revenue % | 22.73% | 22.98% | 26.08% | 24.45% | 20.12% | 17.03% | 17.15% | 20.23% | 22.39% | 26.14% | 31.94% | 35.35% | 40.6% | 54.07% | 128.48% | 339.44% |
| Depreciation & Amortization | 5.52M | 5.23M | 5.78M | 4.53M | 3.02M | 3.38M | 3.33M | 3.77M | 3.4M | 3.92M | 4.06M | 3.22M | 2.46M | 2.25M | 15.16M | 13.59M |
| Combined Ratio % | 39.9% | 34.82% | 32.49% | 27.24% | 2.96% | 20.05% | 48.69% | 24.03% | 24% | 30.87% | 31.94% | 35.35% | 43.24% | 55.84% | 128.48% | 339.44% |
| Operating Income | 828.78M | 821.86M | 855.49M | 823M | 988.19M | 822.31M | 490.1M | 659.06M | 546.7M | 398.57M | 311.88M | 228.4M | 135.93M | 58.03M | -13.88M | -34.45M |
| Operating Margin % | 60.1% | 65.18% | 67.51% | 72.76% | 97.04% | 79.95% | 51.31% | 75.97% | 76% | 69.13% | 68.06% | 64.65% | 56.76% | 44.16% | -28.48% | -239.44% |
| Operating Income Growth % | - | -3.93% | 3.95% | -16.72% | 20.17% | 67.79% | -25.64% | 20.55% | 37.17% | 27.79% | 36.55% | 68.03% | 134.25% | 518.18% | 59.72% | - |
| EBITDA | 834.29M | 827.1M | 861.27M | 827.52M | 991.21M | 825.69M | 493.42M | 662.83M | 550.1M | 402.49M | 315.95M | 231.62M | 138.39M | 60.28M | 1.28M | -20.86M |
| EBITDA Margin % | 60.5% | 65.59% | 67.97% | 73.16% | 97.34% | 80.28% | 51.66% | 76.4% | 76.47% | 69.81% | 68.95% | 65.56% | 57.79% | 45.87% | 2.63% | -144.97% |
| Interest Expense | 32.61M | 32.7M | 35.32M | 30.14M | 15.61M | 8.28M | 9.07M | 10.15M | 10.18M | 5.18M | 426K | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | -24.44M | -32.7M | -35.32M | -30.14M | -15.61M | -8.28M | -9.07M | -10.15M | -10.18M | -5.18M | -426K | 0 | 0 | 0 | 1.28M | -20.86M |
| Pretax Income | 820.62M | 821.86M | 855.49M | 823M | 988.19M | 822.31M | 490.1M | 659.06M | 546.7M | 398.57M | 311.88M | 228.4M | 135.93M | 58.03M | -13.88M | -34.45M |
| Pretax Margin % | 59.51% | 65.18% | 67.51% | 72.76% | 97.04% | 79.95% | 51.31% | 75.97% | 76% | 69.13% | 68.06% | 64.65% | 56.76% | 44.16% | -28.48% | -239.44% |
| Income Tax | 140.74M | 131.89M | 126.09M | 126.61M | 156.83M | 140.53M | 77.06M | 103.35M | 79.34M | 18.82M | 89.28M | 71.07M | 47.43M | -7.39M | -333K | -895K |
| Effective Tax Rate % | 17.15% | 16.05% | 14.74% | 15.38% | 15.87% | 17.09% | 15.72% | 15.68% | 14.51% | 4.72% | 28.62% | 31.12% | 34.89% | -12.73% | 2.4% | 2.6% |
| Net Income | 679.87M | 689.97M | 729.4M | 696.39M | 831.35M | 681.78M | 413.04M | 555.71M | 467.36M | 379.75M | 222.61M | 157.33M | 88.5M | 65.41M | -13.54M | -33.55M |
| Net Margin % | 49.31% | 54.72% | 57.56% | 61.57% | 81.64% | 66.29% | 43.24% | 64.05% | 64.97% | 65.87% | 48.58% | 44.53% | 36.96% | 49.78% | -27.8% | -233.22% |
| Net Income Growth % | -3.27% | -5.41% | 4.74% | -16.23% | 21.94% | 65.06% | -25.67% | 18.9% | 23.07% | 70.59% | 41.49% | 77.78% | 35.29% | 583% | 59.64% | - |
| EPS (Diluted) | 7.57 | 6.90 | 6.85 | 6.50 | 7.72 | 6.11 | 3.88 | 5.66 | 4.77 | 3.99 | 2.41 | 1.72 | 1.03 | 0.70 | -0.35 | -0.87 |
| EPS Growth % | 6.55% | 0.73% | 5.38% | -15.8% | 26.35% | 57.47% | -31.45% | 18.66% | 19.55% | 65.56% | 40.12% | 66.99% | 47.14% | 300% | 59.77% | - |
| EPS (Basic) | - | 6.97 | 6.92 | 6.56 | 7.75 | 6.13 | 3.89 | 5.68 | 4.80 | 4.07 | 2.45 | 1.74 | 1.05 | 0.90 | -0.35 | -0.87 |
| Diluted Shares Outstanding | 89.77M | 100.02M | 106.55M | 107.13M | 107.65M | 111.56M | 106.38M | 98.23M | 97.97M | 95.21M | 92.25M | 91.74M | 85.6M | 18.1M | 38.45M | 38.45M |
Quick answers to the most common questions about buying ESNT stock.
For fiscal year 2025, Essent Group Ltd. (ESNT) reported total revenue of $1.26B. This represents a 8663.8% increase compared to $14.4M in 2011.
Essent Group Ltd. (ESNT) is profitable, generating $690.0M in net income for the fiscal year ending 2025 with a net profit margin of 54.7%.
Essent Group Ltd. (ESNT) reported an operating income of $821.9M, resulting in an operating profit margin of 65.2%. This margin reflects the operational efficiency of the business before interest and taxes.
Essent Group Ltd. (ESNT) generated $1.11B in gross profit for the year, representing a gross profit margin of 88.2%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Housing credit cycle exposure
Metrics are mathematically derived from official filings.
Flat Top Line Despite Recurring Premium Base
Based on reported quarterly figures, ESNT's revenue moved from $318.7M in Q2 2024 to $374.2M in Q3 2026, but year-over-year growth has hovered near flat, suggesting volume gains are offsetting little real momentum in new originations and pricing.
The recurring premium base from the existing insurance in force is doing most of the work in sustaining revenue, which is consistent with a mortgage insurer whose new insurance written is pressured by elevated mortgage rates. Investors should monitor persistency and new insurance written in upcoming filings, since flat growth leaves the top-line thesis dependent on credit performance rather than volume expansion.
Underwriting Profitability Remains Elevated
Reported combined ratios of 44.6% in Q3 2026 and 36.5% in Q2 2026 indicate underwriting margins well below the 100% breakeven threshold, though the Q3 2026 ratio rose versus the prior quarter as loss expense increased to $83.5M.
The sharp rise in claims and loss expense in Q3 2026 compared with the roughly $17M to $49M range of prior quarters may reflect cure-rate normalization or reserve adjustments, and the data alone does not establish which. The combined ratio structure suggests the core underwriting book remains highly profitable, but the trend warrants monitoring to determine whether the Q3 increase is transitory or the start of a sustained shift in loss experience.
Reserve Quality Requires Closer Scrutiny
Quarterly loss ratios ranged from negative territory in Q2 2024 to 22.3% in Q3 2026, and the absence of loss triangle data in the supplied figures limits assessment of whether prior-year releases are flattering current earnings.
Near-zero loss expense in Q2 2024 and the low 5.2% loss ratio in Q2 2025 could indicate favorable reserve development, but the supplied data does not confirm this. Analysts should examine the loss development triangles in the footnotes before concluding whether current margins reflect run-rate underwriting or reserve releases.
Operating Leverage Holds Through Revenue Plateau
Operating income of $207.2M on $374.2M revenue in Q3 2026 implies an operating margin near 55%, while reported EPS of $1.82 fell short of the $1.87 consensus level despite the margin base.
The gap between operating income and net income suggests a meaningful tax or other below-the-line drag that the supplied data does not fully decompose. The EPS miss, combined with the absence of forward guidance, suggests near-term earnings visibility is limited even though the cost structure remains efficient.
Earnings Quality Could Mask Credit Deterioration
If the Q2 2024 near-zero loss expense and the subsequent low loss ratios reflect reserve releases rather than sustained credit strength, reported profitability may overstate the underlying earnings power of the book.
Mortgage insurance earnings are sensitive to how quickly delinquencies cure, and a period of benign loss experience can coincide with favorable estimate revisions that reverse later. The recent rise in loss expense in Q3 2026 may be an early signal of this reversal, though the supplied data is insufficient to confirm it.